RPID Stock Overview
A life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rapid Micro Biosystems, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.84 |
| 52 Week High | US$1.19 |
| 52 Week Low | US$0.74 |
| Beta | 1.18 |
| 1 Month Change | -3.67% |
| 3 Month Change | -11.68% |
| 1 Year Change | -22.31% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -96.08% |
Recent News & Updates
Recent updates
Rapid Micro to introduce RMBNucleus software for mold detection in pharma manufacturing
Oct 10Companies Like Rapid Micro Biosystems (NASDAQ:RPID) Are In A Position To Invest In Growth
May 09
Earnings Release: Here's Why Analysts Cut Their Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Price Target To US$17.67
Mar 08We're Not Very Worried About Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate
Feb 07Shareholder Returns
| RPID | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 3.6% | -0.1% | 1.2% |
| 1Y | -22.3% | 8.0% | 27.7% |
Return vs Industry: RPID underperformed the US Life Sciences industry which returned 8% over the past year.
Return vs Market: RPID underperformed the US Market which returned 27.7% over the past year.
Price Volatility
| RPID volatility | |
|---|---|
| RPID Average Weekly Movement | 7.9% |
| Life Sciences Industry Average Movement | 6.8% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: RPID's share price has been volatile over the past 3 months.
Volatility Over Time: RPID's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 193 | Rob Spignesi | www.rapidmicrobio.com |
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables.
Rapid Micro Biosystems, Inc. Fundamentals Summary
| RPID fundamental statistics | |
|---|---|
| Market cap | US$36.32m |
| Earnings (TTM) | -US$51.90m |
| Revenue (TTM) | US$23.10m |
1.6x
P/S Ratio-0.7x
P/E RatioIs RPID overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RPID income statement (TTM) | |
|---|---|
| Revenue | US$23.10m |
| Cost of Revenue | US$28.31m |
| Gross Profit | -US$5.22m |
| Other Expenses | US$46.68m |
| Earnings | -US$51.90m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.21 |
| Gross Margin | -22.59% |
| Net Profit Margin | -224.73% |
| Debt/Equity Ratio | 0% |
How did RPID perform over the long term?
See historical performance and comparison